Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global Public Health Partnering Deal Trends, Players and Financials 2012-2018 - ResearchAndMarkets.com

Research and Markets
Posted on: 23 Mar 18

The "Global Public Health Partnering 2012-2018: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.

Global Public Health Partnering 2012 to 2018 provides the full collection of Public Health disease deals signed between the world's pharmaceutical and biotechnology companies since 2012.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Public Health disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Public Health deals.

The report presents financial deal terms values for Public Health deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.

In addition, a comprehensive appendix is provided with each report of all Public Health partnering deals signed and announced since 2012. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

Report scope

  • Trends in Public Health dealmaking in the biopharma industry since 2012
  • Analysis of Public Health deal structure
  • Access to headline, upfront, milestone and royalty data
  • Access to hundreds of Public Health deal contract documents
  • Comprehensive access to over 3500 Public Health deal records
  • The leading Public Health deals by value since 2012
  • Most active Public Health dealmakers since 2012

Key Topics Covered:

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in Public Health dealmaking

Chapter 3 - Financial deal terms for Public Health partnering

Chapter 4 - Leading Public Health deals and dealmakers

Chapter 5 - Public Health contract document directory

Chapter 6 - Public Health dealmaking by therapeutic target

For more information about this report visit https://www.researchandmarkets.com/research/m9z9ng/global_public?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20180323005181/en/

Business Wire
www.businesswire.com

Last updated on: 23/03/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.